| Ascorbic Acid impurity 12 | 67776-07-2 | C7H12O7 |
| Ascorbic Acid Impurity 13 | 80-71-7 | C6H8O2 |
| Ascorbic Acid impurity 14 | 33124-69-5 | C6H6O6 |
| Ascorbic Acid Impurity 14 | 496-64-0 | C5H4O3 |
| Ascorbic Acid Impurity 15 | 17678-19-2 | C6H6O3 |
| Ascorbic Acid Impurity 16 | 22694-55-9 | C5H6O3 |
| Ascorbic Acid impurity 16 | 3445-22-5 | C6H8O7 |
| Ascorbic Acid Impurity 17 | 51490-07-4 | C10H8O3 |
| Ascorbic Acid Impurity 19 | 552-86-3 | C10H8O4 |
| Ascorbic Acid impurity 19 (Sodium salt) | 134-03-2 | C6H7NaO6 |
| Ascorbic Acid impurity 20 | 16533-48-5 | C6H10O7 |
| Ascorbic Acid impurity 24 | 19192-77-9 | C6H6O6 |
| Ascorbic Acid impurity 25 | 10504-35-5 | C6H8O6 |
| Ascorbic Acid impurity 32 | 86404-04-8 | C8H12O6 |
| Ascorbic acid impurity C | 21675-47-8 | C6H10O7 |
| Ascorbic acid impurity C | 21675-47-8 | C6H10O7 |
| Ascorbic acid impurity D | 67776-07-2 | C7H12O7 |
| Ascorbic Acid impurity F | 89-65-6 | C6H8O6 |
| Ascorbic Acid Impurity F | 89-65-6 | C6H8O6 |
| Ascorbic Acid impurity G | 66757-69-5 | C6H6O7 |
| Ascorbic Acid impurity H | 122046-79-1 | C7H8O7 |
| Ascorbyl Tetraisopalmitate | 183476-82-6 | C70H128O10 |
| Asenapine | 65576-45-6 | C17H16ClNO |
| AsenapineImpurity1 | 129385-61-1 | C17H10ClNO3 |
| Asp9-Bivalirudin | Not available | C25H33NaO7 |
| Asp-Phe | 13433-09-5 | C13H16N2O5 |
| Asparagine EP Impurity C | 98490-54-1 | C8H12N4O4 |
| Asparagine impurity C | 98490-54-1 | C8H12N4O4 |
| Asparagine impurity C | 98490-54-1 | C8H12N4O4 |
| Asparagine Monohydrate (L-Asparagine Monohydrate) | 5794-13-8 | C4H10N2O4 |
| Asparagine Related Compound A | 98490-54-1 | C8H12N4O4 |
| Aspartame EP Impurity A | 5262-10-2 | C13H14N2O4 |
| Aspartame EP Impurity B | 13433-09-5 | C13H16N2O5 |
| Aspartame EP Impurity C (Leucine EP Impurity C) | 63-91-2 | C9H11NO2 |
| Aspartame Imp. B (EP): L-Aspartyl-L-phenylalanine | 13433-09-5 | C13H16N2O5 |
| Aspartame Imp. C (EP): Phenylalanine | 150-30-1 | C9H11NO2 |
| Aspartame impurity 3 | 24250-84-8 | C9H10BrNO2 |
| Aspartame impurity A | 5262-10-2 | C13H14N2O4 |
| Aspartame Related Compound A | 5262-10-2 | C13H14N2O4 |
| Aspartic Acid Imp. B (Pharmeuropa): (E)-Butenedioic Acid (Fumaric Acid) | 110-17-8 | C4H4O4 |
| Aspartic Acid Imp. D (Pharmeuropa): (S)-2-Aminopropanoic Acid (Alanine) | 56-41-7 | C3H7NO2 |
| Aspartic Acid Imp. F (Pharmeuropa): (2S)-2,5-Diamino-5- oxopentanoic Acid (L-Glutamine) | 56-85-9 | C5H10N2O3 |
| Aspirin Impurity 2 | 318515-20-7 | C12H10N2O3 |
| Aspirin Impurity 3 | 15540-79-1 | C8H7NO5 |
| Aspirin Impurity 4 | 2513-33-9 | C14H10O5 |
| Aspirin Impurity 11 | 85531-16-4 | C23H16O8 |
| Aspirin Impurity 16 | 24719-72-0 | C15H16O10 |
| Aspirin Impurity 19 | 85531-25-5 | C15H12O5 |
| Aspirin Impurity 36 | 7695-70-7 | C13H14O9 |
| Aspirin Impurity A-D4 (Aspirin Impurity 12) | 152404-47-2 | C7H6O3 |
| Astragalin | 480-10-4 | C21H20O11 |
| Astragaloside A | 83207-58-3 | C41H68O14 |
| Astragaloside IV Control | 84687-43-4 | C41H68O14 |
| Ataluren impurities1 | 775304-03-5 | C16H12N2O4 |
| Ataluren impurities3 | 775304-56-8 | C15H9FN2O3 |
| Ataluren impurities6 | 775304-60-4 | C16H11FN2O3 |
| Atazanavir (Sulfate) | 229975-97-7 | C38H54N6O11S |
| Atazanavir EP Impurity A | 4385-62-0 | C12H9NO2 |
| Atazanavir EP Impurity B | 127406-56-8 | C12H9NO |
| Atazanavir EP Impurity C | 1192224-24-0 | C26H43N5O7 |
| Atazanavir EP Impurity D | Not available | C34H33N5O |
| Atazanavir EP Impurity E (Atazanavir S,R,S,S-Diastereomer) | Not available | C38H52N6O7 |
| Atazanavir EP Impurity F (Atazanavir R,S,S,S-Diastereomer) | 1332981-14-2 | C38H52N6O7 |
| Atazanavir EP Impurity G (Atazanavir S,S,S,R-Diastereomer) | 1332981-16-4 | C38H52N6O7 |
| Atazanavir EP Impurity I | Not available | C42H46N6O4 |
| Atazanavir EP Impurity J | 198904-86-8 | C32H42N4O5 |
| Atazanavir EP Impurity K | 162537-11-3 | C8H15NO4 |
| Atazanavir for system suitability | 198904-31-3 | C38H52N6O7 |
| Atazanavir Impurity 1 | 1292296-09-3 | C38H52N6O7 |
| Atazanavir Impurity 5 | 1292296-10-6 | C38H52N6O7 |
| Atazanavir Impurity 6 | 1006868-81-0 | C32H42N4O5 |
| Atazanavir Impurity 7 | 1192224-26-2 | C36H50N6O5 |
| Atazanavir Impurity 8 | 1028634-76-5 | C36H50N6O5 |
| Atazanavir Impurity 17 | 98760-08-8 | C15H21NO3 |
| Atazanavir Impurity 18 | 156474-22-5 | C15H21NO3 |
| Atazanavir Impurity 19 | 198904-85-7 | C17H21N3O2 |
| Atazanavir Impurity 20 | 102123-74-0 | C15H20ClNO3 |
| Atazanavir Impurity 21 | 98737-29-2 | C15H21NO3 |
| Atazanavir Impurity 24 | 156474-21-4 | C15H21NO3 |
| Atazanavir impurity K | 162537-11-3 | C8H15NO4 |
| Atazanavir Related Compound A | 162537-11-3 | C8H15NO4 |
| Atemisinic Aldehyde Impurity (Artemisinin) | 125276-60-0 | C15H22O |
| Atenolol EP Impurity A | 17194-82-0 | C8H9NO2 |
| Atenolol EP Impurity B | 61698-76-8 | C11H15NO4 |
| Atenolol EP Impurity D | 115538-83-5 | C11H14ClNO3 |
| Atenolol EP Impurity E | 141650-31-9 | C19H22N2O5 |
| Atenolol EP Impurity F | 87619-83-8 | C25H35N3O6 |
| Atenolol EP Impurity G | 56392-14-4 | C14H21NO4 |
| Atenolol EP Impurity H | 29277-73-4 | C14H20N2O2 |
| Atenolol EP Impurity I | 1797116-92-7 | C13H20N2O3 |
| Atenolol EP Impurity J | 81346-71-6 | C11H16N2O3 |
| Atenolol Imp. A (EP): 2-(4-Hydroxyphenyl)- acetamide | 17194-82-0 | C8H9NO2 |
| Atenolol Imp. B (EP): 2-[4-[(2RS)-2,3-Dihydroxy- propoxy]phenyl]acetamide | 61698-76-8 | C11H15NO4 |
| Atenolol Imp. D (EP): 2-[4-[(2RS)-3-Chloro-2- hydroxypropoxy]phenyl]acetamide | 115538-83-5 | C11H14ClNO3 |
| Atenolol Imp. E (EP): 2,2'-[(2-Hydroxypropane-1,3- diyl)bis(oxy-4,1-phenylene)]diacetamide | 141650-31-9 | C19H22N2O5 |
| Atenolol Imp. F (EP): 2,2'-[[(1-Methylethyl)- imino]bis[(2-hydroxypropane-3,1- diyl)oxy-4,1-phenylene]]diacetamide | 87619-83-8 | C25H35N3O6 |
| Atenolol Imp. G (EP): 2-[4-[(2RS)-2-Hydroxy-3- [(1-methylethyl)amino]propoxy]phenyl]- acetic Acid | 56392-14-4 | C14H21NO4 |
| Atenolol Imp. H (EP): 2-[4-[(2RS)-2-Hydroxy-3- [(1-methylethyl)amino]propoxy]phenyl]- acetonitrile | 29277-73-4 | C14H20N2O2 |
| Atenolol Impurity C | 29122-69-8 | C11H13NO3 |
| Atenolol impurity standard | 29122-68-7 | C14H22N2O3 |
| Atenolol Related Compound A | 17194-82-0 | C8H9NO2 |
| Atenolol Related Compound B | 61698-76-8 | C11H15NO4 |
| Atenolol Related Compound C | 29122-69-8 | C11H13NO3 |
| Atenolol Related Compound D | 115538-83-5 | C11H14ClNO3 |
| Atenolol Related Compound E | 141650-31-9 | C19H22N2O5 |
| Atenolol Related Compound F | 87619-83-8 | C25H35N3O6 |
| Atipamezole Impurity 1 | 917220-61-2 | C14H16N2O |
| Atipamezole Impurity 2 | 104054-82-2 | C14H14N2O |
| Atomoxetine | 83015-26-3 | C17H21NO |
| Atomoxetine EP impurity A | 56161-70-7 | C16H19NO |
| Atomoxetine EP Impurity A HCl | 873310-33-9 | C16H20ClNO |
| Atomoxetine EP Impurity B | 105314-53-2 | C17H21NO |
| Atomoxetine EP Impurity B (Hydrochloride) | 82857-39-4 | C17H22ClNO |
| Atomoxetine EP Impurity C HCl | 1643684-06-3 | C17H22ClNO |
| Atomoxetine EP Impurity D (Hydrochloride) | 1643684-05-2 | C17H22ClNO |
| Atomoxetine EP impurity D (isomer) | 1643684-02-9 | C17H21NO |
| Atomoxetine EP Impurity F | Not available | C17H20FNO |
| Atomoxetine EP impurity F HCl | Not available | C17H21ClFNO |
| Atomoxetine EP Impurity G | Not available | C27H34N2O2 |
| Atomoxetine EP impurity G (isomer) | 2706536-33-4 | C27H34N2O2 |
| Atomoxetine EP impurity G DiHCl | Not available | C27H36Cl2N2O2 |
| Atomoxetine EP Impurity H | 42142-52-9 | C10H15NO |
| Atomoxetine for impurity A identification | 82248-59-7 | C17H22ClNO |
| Atomoxetine Impurity 10 | 82248-59-7 | C17H22ClNO |
| Atomoxetine Impurity 11 | 42064-62-0 | C18H24ClNO |
| Atomoxetine Impurity 13 | 115290-81-8 | C10H15NO |
| Atomoxetine Impurity 16 | 873310-31-7 | C17H22ClNO |
| Atomoxetine Impurity 17 | 82857-40-7 | C17H22ClNO |
| Atomoxetine Impurity 20 | 857786-66-4 | C19H25NO2 |
| Atomoxetine Impurity 21 | 79130-51-1 | C11H17Cl2N |
| Atomoxetine Impurity 22 | 128036-32-8 | C10H15Cl2N |
| Atomoxetine Impurity 25 | 5409-62-1 | C17H20ClNO |
| Atomoxetine Impurity 27 | 83554-67-0 | C10H13N |
| Atomoxetine Impurity 28 | 881995-45-5 | C19H23NO2 |
| Atomoxetine Impurity 30 | 881995-46-6 | C16H20ClNO |
| Atomoxetine Impurity 31 | 1212215-97-8 | C16H20ClNO |
| Atomoxetine Impurity 37 | 2659259-65-9 | C10H14N2O2 |
| Atomoxetine impurity B | Not available | C17H21NO |
| Atomoxetine impurity D | Not available | C17H21NO |
| Atomoxetine impurity D | Not available | C17H21NO |
| Atomoxetine Related Compound A | 42142-52-9 | C10H15NO |
| Atomoxetine Related Compound B | 873310-28-2 | C17H22ClNO |
| Atomoxetine-d3 Hydrochloride | 1217776-38-9 | C17H22ClNO |
| Atorvastatin | 134523-00-5 | C33H35FN2O5 |
| Atorvastatin 3-Deoxyhept-2E-Enoic Acid | 1105067-93-3 | C33H33FN2O4 |
| Atorvastatin Acetonide tert-Butyl Ester | 125971-95-1 | C40H47FN2O5 |
| Atorvastatin Amlodipine Dimer | 425408-16-8 | C53H58ClFN4O9 |
| Atorvastatin Calcium Impurity PD (Atorvastatin Impurity 12) | 2591410-04-5 | C33H33FN2O6 |
| Atorvastatin Calcium Trihydrate Imp. D (EP): 3-[(4-Fluorophenyl)carbonyl]- 2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carbox- amide | 148146-51-4 | C26H22FNO4 |
| Atorvastatin Calcium Trihydrate Imp. G (EP) as Calcium Salt: (3R,5R)-7-[2-(4- Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl]-5-hydroxy- 3-methoxyheptanoic Acid Calcium Salt (3-O-Methylatorvastatin Calcium Salt) | 887196-29-4 | C68H72CaF2N4O10 |
| Atorvastatin Calcium Trihydrate Imp. H (EP): (4R,6R)-6-[2-[2-(4-Fluorophenyl)- 5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)- 1H-pyrrol-1-yl]ethyl]-4-hydroxytetrahydro-2H- pyran-2-one (Atorvastatin Lactone) | 125995-03-1 | C33H33FN2O4 |
| Atorvastatin Cyclic (Fluorophenyl) Impurity (Atorvastatin Impurity 11) | 873950-18-6 | C33H35FN2O7 |
| Atorvastatin Cyclic (Fluorophenyl) Sodium Salt Impurity | 1315629-79-8 | C33H34FN2NaO7 |
| Atorvastatin Cyclic (Fluorophenyl) Sodium Salt Impurity | 1315629-79-8 | C33H34FN2NaO7 |
| Atorvastatin Cyclic (Isopropyl) Impurity (Atorvastatin Impurity 10) | 873950-17-5 | C33H35FN2O7 |
| Atorvastatin Cyclic Sodium Salt (Isopropyl) Impurity | 1316291-19-6 | C33H34FN2NaO7 |
| Atorvastatin Cyclic Sodium Salt (Isopropyl) Impurity | 1316291-19-6 | C33H34FN2NaO7 |
| Atorvastatin Defluorinated Impurity (Atorvastatin Impurity 5) | 1105067-91-1 | C40H48N2O5 |
| Atorvastatin Dehydro Lactone | 442851-50-5 | C33H31FN2O3 |
| Atorvastatin EP Impurity A | 433289-84-0 | C33H36N2O5 |
| Atorvastatin EP Impurity A (Calcium Salt) | 433289-83-9 | C66H70CaN4O10 |
| Atorvastatin EP Impurity D | 148146-51-4 | C26H22FNO4 |
| Atorvastatin EP Impurity E | 501121-34-2 | C33H35FN2O5 |
| Atorvastatin EP Impurity E Sodium Salt | 1428118-38-0 | C33H34FN2NaO5 |
| Atorvastatin EP Impurity G (Calcium Salt) | 887196-29-4 | C68H72CaF2N4O10 |
| Atorvastatin EP Impurity H | 125995-03-1 | C33H33FN2O4 |
| Atorvastatin EP Impurity J | 1105067-93-3 | C33H33FN2O4 |
| Atorvastatin Epoxy Pyrrolooxazin 6-hydroxy analog | 1316291-19-6 | C33H34FN2NaO7 |
| Atorvastatin Epoxy Pyrrolooxazin 7-hydroxy analog | 1315629-79-8 | C33H34FN2NaO7 |
| Atorvastatin Epoxy Tetrahydrofuran Impurity | 873950-19-7 | C26H24FNO5 |
| Atorvastatin Epoxy Tetrahydrofuraran analog | 873950-19-7 | C26H24FNO5 |
| Atorvastatin Epoxydione Impurity | 148146-51-4 | C26H22FNO4 |
| Atorvastatin Ethyl Ester | 1146977-93-6 | C35H39FN2O5 |
| Atorvastatin Impurity 15 | 125971-94-0 | C14H23NO4 |
| Atorvastatin Impurity 20 | 125971-95-1 | C40H47FN2O5 |
| Atorvastatin Impurity 21 | 1035205-25-4 | C36H41FN2O5 |
| Atorvastatin Impurity 30 | 947586-93-8 | C14H27NO4 |
| Atorvastatin Impurity 31 | 1105067-89-7 | C14H27NO4 |
| Atorvastatin Impurity 32 | 2088732-01-6 | C14H27NO4 |
| Atorvastatin Impurity 33 | 2299304-89-3 | C24H44N2O7 |
| Atorvastatin Impurity 35 | 1797905-42-0 | C26H24FNO3 |
| Atorvastatin Impurity 36 | 444577-70-2 | C26H25NO3 |
| Atorvastatin Impurity 37 | 693793-82-7 | C26H23F2NO3 |
| Atorvastatin Impurity 39 | 2243639-97-4 | C33H35FN2O5 |
| Atorvastatin Impurity 41 | 196085-84-4 | C14H23NO4 |
| Atorvastatin Impurity 42 | 196085-85-5 | C14H23NO4 |
| Atorvastatin Impurity 43 | 1403667-07-1 | C14H9Cl2FO |
| Atorvastatin Impurity 44 | 131275-93-9 | C33H34FN2NaO5 |
| Atorvastatin Impurity 44 | 1353049-81-6 | C37H41FN2O5 |
| Atorvastatin Impurity 45 | 887196-30-7 | C33H33FN2O5 |
| Atorvastatin Impurity 46 | 807312-27-2 | C10H15NO4 |
| Atorvastatin Impurity 46 | 581772-29-4 | C36H39FN2O5 |
| Atorvastatin Impurity 48 | 1391052-00-8 | C33H32FN2NaO5 |
| Atorvastatin Impurity 50 | 134394-98-2 | C37H41FN2O5 |
| Atorvastatin Impurity 52 | 134523-03-8 | C66H68CaF2N4O10 |
| Atorvastatin Impurity 52 | 887196-25-0 | C66H68CaF2N4O10 |
| Atorvastatin Impurity 54 | 1050631-82-7 | C24H21F2NO3 |
| Atorvastatin Impurity 56 | 1116118-82-1 | C50H64FN3O8 |
| Atorvastatin Impurity 57 | 737755-14-5 | C11H23NO4 |
| Atorvastatin Impurity 57 | 472967-95-6 | C40H47FN2O5 |
| Atorvastatin Impurity 58 | 1428118-12-0 | C37H43FN2O5 |
| Atorvastatin Impurity 59 | 887470-43-1 | C33H35FN2O7 |
| Atorvastatin Impurity 63 | 1821498-27-4 | C27H30FNO6 |
| Atorvastatin Impurity 64 | 666714-64-3 | C26H23FN2O |
| Atorvastatin Impurity 64 | 125971-93-9 | C11H19NO4 |
| Atorvastatin Impurity 65 | 1173184-78-5 | C20H18FNO2 |
| Atorvastatin Impurity 65 | 125988-01-4 | C11H17NO4 |
| Atorvastatin impurity 66 | 693793-87-2 | C40H46F2N2O5 |
| Atorvastatin Impurity 68 | 1112262-71-1 | C39H45FN2O5 |
| Atorvastatin Impurity 69 | 616201-27-5 | C38H43FN2O5 |
| Atorvastatin Impurity 71 | 186508-95-2 | C14H23NO4 |
| Atorvastatin Impurity 71 | 214217-88-6 | C33H35FN2O6 |
| Atorvastatin Impurity 72 | 265989-46-6 | C33H34CaFN2O6+ |
| Atorvastatin Impurity 73 | 1817798-20-1 | C26H24FNO3 |
| Atorvastatin Impurity 74 | 62148-67-8 | C14H10ClFO |
| Atorvastatin Impurity 79 | 125971-96-2 | C26H24FNO3 |
| Atorvastatin impurity A | 433289-84-0 | C33H36N2O5 |
| Atorvastatin impurity B | 791553-16-7 | C33H35FN2O5 |
| Atorvastatin impurity C | Not available | C33H34F2N2O5 |
| Atorvastatin Impurity C | 693793-53-2 | C66H66CaF4N4O10 |
| Atorvastatin impurity D | 148146-51-4 | C26H22FNO4 |
| Atorvastatin Impurity E | 1105067-88-6 | C66H68CaF2N4O10 |
| Atorvastatin impurity E | 501121-34-2 | C33H35FN2O5 |
| Atorvastatin Impurity F | 887196-24-9 | C40H48FN3O8 |
| Atorvastatin Impurity F (Sodium salt) | 1371615-56-3 | C40H47FN3NaO8 |
| Atorvastatin Impurity F calcium salt | 1105067-87-5 | C80H94CaF2N6O16 |
| Atorvastatin Impurity J reference substance | 345891-62-5 | C34H37FN2O5 |
| Atorvastatin Impurity K | 906552-19-0 | C33H33FN2O5 |
| Atorvastatin Impurity M | 1146977-93-6 | C35H39FN2O5 |
| Atorvastatin Impurity O reference substance | 134395-00-9 | C37H43FN2O5 |
| Atorvastatin Isopropyl Ester | 1035205-25-4 | C36H41FN2O5 |
| Atorvastatin L1 Diastereomer (Atorvastatin Impurity 17) | 1105067-90-0 | C40H47FN2O5 |
| Atorvastatin Lactam Impurity | 906552-18-9 | C33H35FN2O6 |
| Atorvastatin Lactam Impurity Sodium Salt | 148217-40-7 | C33H34FN2NaO6 |
| Atorvastatin Lactam Phenanthrene Calcium Salt Impurity (mixture of diastereomers) | 148127-12-2 | C66H64CaF2N4O12 |
| Atorvastatin Lactam Sodium Salt Impurity | 148217-40-7 | C33H34FN2NaO6 |
| Atorvastatin Lactone | 125995-03-1 | C33H33FN2O4 |
| Atorvastatin Methyl Ester | 345891-62-5 | C34H37FN2O5 |
| Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide | 1105067-87-5 | C80H94CaF2N6O16 |
| Atorvastatin Oxirane Impurity | 1246818-88-1 | C26H24FNO3 |
| Atorvastatin Related Compound B | 887196-25-0 | C66H68CaF2N4O10 |
| Atorvastatin Related Compound B (3S,5R isomer, or (3S,5R)-7-[3-(phenylcarba- moyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl- 1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid cal- cium salt) | Not available | C66H68CaF2N4O10 |
| Atorvastatin Related Compound C | 693793-53-2 | C66H66CaF4N4O10 |
| Atorvastatin Related Compound C (Difluoro impurity, or (3R,5R)-7-[3-(phenylcarba- moyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H- pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt) | Not available | C66H66CaF4N4O10 |
| Atorvastatin Related Compound D | 148146-51-4 | C26H22FNO4 |
| Atorvastatin Related Compound E | 1105067-88-6 | C66H68CaF2N4O10 |
| Atorvastatin Related Compound E (3S, 5S enantiomer of Atorvastatin Calcium) | Not available | C66H68CaF2N4O10 |
| Atorvastatin Related Compound H | 125995-03-1 | C33H33FN2O4 |
| Atorvastatin Related Compound I | 125971-95-1 | C40H47FN2O5 |
| Atorvastatin tert-Butyl Ester | 134395-00-9 | C37H43FN2O5 |